Previous 10 | Next 10 |
Seasoned life sciences expert brings further global portfolio management and financial expertise from 20 years at Merck & Co. Inc. to the PureTech board Ms. Barber-Lui will also become chair of the Audit Committee of the board PureTech Health plc (Nasdaq: PRT...
Jon David brings deep expertise in building and launching engaging products to the Akili leadership team PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Found...
New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch Gelesis has projected $58 million in net revenue in this first full launch year 2022 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“Pur...
Akili, the maker of EndeavorRx ® , the first-and-only FDA-cleared prescription video game treatment, joins the ranks of Canva, Microsoft, SpaceX, and more PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a ...
Electroencephalography data (EEG) demonstrate enhancement of brain activity specific to attention function in children 8-12 with ADHD following AKL-T01 (EndeavorRx) treatment Data show correlation between targeted activity in the brain and objective improvements in attention f...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted today that its Founded Entity, Akili Interactive (“Akili”), a leading digital medicine company developing cognitive t...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that Bharatt Chowrira, Ph.D., J.D....
Plenity is designed to help people feel satisfied with smaller portions so they can eat less and lose weight, while enjoying the foods they love Gelesis®, the maker of Plenity, began trading on the New York Stock Exchange earlier this month PureTech Health plc...
In addition to PureTech’s advanced Wholly Owned Pipeline, Founded Entities are an additional source of value and Akili is now set to join the growing list of publicly-traded Founded Entities for PureTech, which also include Karuna Therapeutics (Nasdaq: KRTX), Vor Biopharma (Nas...
Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and will ring the opening bell on Tuesday, January 18 PureTech...
News, Short Squeeze, Breakout and More Instantly...
Appointments support ongoing Phase 2 COLLECTiVE202 trial of VE202, pivotal Phase 3 RESTORATiVE303 trial of VE303 and planning for commercial stage activity PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated...
2024-06-27 14:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, confirms that the Tender Offer announced by the Company on 20 May 2024 is now ...